By Bill Wichert ( December 13, 2017, 10:47 PM EST) -- A New Jersey federal judge indicated Wednesday that she would give Celgene Corp. a partial win in an antitrust suit from Mylan Pharmaceuticals Inc. over cancer drugs Thalomid and Revlimid, saying Celgene likely could be held liable for its conduct after Mylan received approval of testing protocols but not before....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.